Clinical Trial Update: Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Lyostypt and Surgicel for hemostasis in arterial bypass anastomosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Lyostypt
• Surgicel (oxidized regenerated cellulose)

Snippet

Sponsor: Aesculap AG | Conditions: Peripheral Vascular Diseases, Hemostasis | Phase 4 | Status: COMPLETED